{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:01:34Z","timestamp":1788800494233,"version":"build-2803163510"},"reference-count":58,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1254\/jphs.10191fp","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T06:09:55Z","timestamp":1300342195000},"page":"279-292","source":"Crossref","is-referenced-by-count":49,"title":["Pharmacological Interaction With the Sigma1 (\u03c31)-Receptor in the Acute Behavioral Effects of Antidepressants"],"prefix":"10.1254","volume":"115","author":[{"given":"Vanessa","family":"Villard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bosker FJ, Westerink BH, Cremers TI, Gerrits M, Van der Hart MG, Kuipers SD, et al. Future antidepressants: what is in the pipeline and what is missing? CNS Drugs. 2004;8:705–732.","DOI":"10.2165\/00023210-200418110-00002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kasper S, Heiden A. Do SSRIs differ in their antidepressant efficacy? Human Psychopharmacol. 1995;10:S163–S172.","DOI":"10.1002\/hup.470100905"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Skolnick P. Antidepressants: new pharmacological strategies. Totowa: Humana Press; 1997.","DOI":"10.1385\/0896034690"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00681.x"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00830-6"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1358\/mf.1998.20.7.485727"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00851-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Leonard BE. The protential contribution of sigma receptors to antidepressant actions. In: Skolnick P, editor. Antidepressants: new pharmacological strategies. Totowa: Humana Press; 1997. p. 159–172.","DOI":"10.1007\/978-1-59259-474-0_9"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00497-9"},{"key":"10","unstructured":"10 Skuza G. Potential antidepressant activity of sigma ligands. Pol J Pharmacol. 2003;55:923–934."},{"key":"11","unstructured":"11 Skuza G, Rogoz Z. Sigma1<\/SUB> receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3-di-o<\/I>-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol J Pharmacol. 2003;55:1149–1152."},{"key":"12","unstructured":"12 Skuza G, Rogoz Z. Effect of a combined treatment with selective σ<\/I> ligands and amantadine in the forced swimming test in rats. Pol J Pharmacol. 2005;54:699–702."},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00147-2"},{"issue":"3","key":"14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","volume":"298","author":"URANI A","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00014-2"},{"issue":"3","key":"16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","volume":"293","author":"HAYASHI T","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.036"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.021413698"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Su TP, Hayashi T. Understanding the molecular mechanism of σ<\/I>1<\/SUB> receptors: towards a hypothesis that σ<\/I>1<\/SUB> receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10:2075–2082.","DOI":"10.2174\/0929867033456783"},{"issue":"1","key":"20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-3565(25)22758-6","volume":"271","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"issue":"1","key":"21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)10951-8","volume":"261","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Maurice T. Neurosteroids and σ<\/I>1<\/SUB> receptors, biochemical and behavioral relevance. Pharmacopsychiatry. 2004;26:S171–S182.","DOI":"10.1055\/s-2004-832675"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR. Sigma1<\/SUB> (σ<\/I>1<\/SUB>) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev. 2002;26:499–527.","DOI":"10.1016\/S0149-7634(02)00017-9"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.81.125"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009;124:195–206.","DOI":"10.1016\/j.pharmthera.2009.07.001"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(01)00112-6"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00254-3"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90734-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Shirayama Y, Nishikawa T, Umino A, Takahashi K. p<\/I>-chlorophenylalanine-reversible reduction of σ<\/I> binding sites by chronic imipramine treatment in rat brain. Eur J Pharmacol. 1993;37:117–126.","DOI":"10.1016\/0014-2999(93)90100-V"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00041-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Bergeron R, Debonnel G, De Montigny C. Modification of the N-methyl-D-aspartate response by antidepressant σ<\/I> receptor ligands. Eur J Pharmacol. 1993;40:319–323.","DOI":"10.1016\/0014-2999(93)90918-8"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(02)00033-5"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.12.018"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508157200"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301047"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Fanselow MS. Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci. 1980;15:177–182.","DOI":"10.1007\/BF03001163"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Bourin M, Hascoet M, Colombel MC, Redrobe JP, Baker GB. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur Neuropsychopharmacol. 1996;6:231–236.","DOI":"10.1016\/0924-977X(96)00025-9"},{"issue":"5","key":"38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2042-7158.1993.tb05578.x","volume":"45","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3573","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Da-Rocha MA, Puech AJ, Thiébot MH. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol. 1997;11:211–218.","DOI":"10.1177\/026988119701100303"},{"issue":"3","key":"40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3565(25)21773-6","volume":"226","year":"1983","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1038\/266730a0"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00772-8"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Sanchez C, Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology. 1997;29:197–205.","DOI":"10.1007\/s002130050181"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 1995;121:66–67.","DOI":"10.1007\/BF02245592"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Hashimoto S, Inoue T, Koyama T. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology. 1996;123:182–186.","DOI":"10.1007\/BF02246175"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00391-3"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.06.061"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01159-1"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.01989.x"},{"key":"50","unstructured":"50 Kinsora JJ, Corbin AE, Snyder BJ, Wiley JN, Meltzer LT, Heffner TG. Effects of igmesine in preclinical antidepressant tests. Soc Neurosci Abstr. 1998;24:744."},{"key":"51","unstructured":"51 Pande AC, Geneve J, Scherrer B. Igmesine, pharmacology and clinical update. In: Abstracts of the Collegium Internationale Neuro-psychopharmacologicum Biennal Meeting; 1988, Glasgow, UK."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Sugimoto Y, Kajiwara Y, Hirano K, Yamada S, Tagawa N, Kobayashi Y, et al. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol. 2008;592:116–122.","DOI":"10.1016\/j.ejphar.2008.07.005"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.001"},{"key":"54","unstructured":"54 Rogoz Z, Skuza G. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Pharmacol Rep. 2006;58:493–500."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Nishimura T, Ishima T, Iyo M, Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One. 2008;3:e2558.","DOI":"10.1371\/journal.pone.0002558"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Kishimoto A, Todani A, Miura J, Kitagaki T, Hashimoto K. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report. Ann Gen Psychiatry. 2010;9:23.","DOI":"10.1186\/1744-859X-9-23"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.9.3774"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.041970"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:44:01Z","timestamp":1741103041000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/115\/3\/115_10191FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.10191fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}